|
Although it's based in neutral Switzerland, Novartis has been aggressive in attacking illnesses on multiple fronts, including pharmaceuticals, vaccines, and consumer health. Its largest division, Pharmaceuticals, develops and manufactures prescription drugs for blood pressure, cancer, and other ailments. Novartis' Sandoz subsidiary produces generic drugs and active pharmaceutical ingredients, while the Vaccine and Diagnostics segment makes immune health and blood-screening tools. Its Alcon division makes ophthalmic drugs, surgery systems, and contact lenses. The Consumer Health unit includes OTC medications such as Excedrin and Theraflu, as well as agricultural animal and pet care products.
|
| | | Contact Information | |
Address: |
Lichtstrasse 35
CH-4056 Basel, Switzerland
| | Phone: | +41-61-324-1111 | | Fax: | +41-61-324-8001 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2012): | 57561.00 M | | Revenue Growth (1 yr): | (-3.10%) | | Employees (2012): | 127,724 | | Employee Growth (1 yr): | 3.30% |
|
|
Key People
| | • |
Chairman:
Daniel L. Vasella
| | • |
CEO:
Joseph (Joe) Jimenez Jr.
| | • |
CFO:
Jonathan R. (Jon) Symonds
|
|
|
